Jeffrey C Ellis

US Patent:

7025734, Apr 11, 2006

Filed:

Sep 28, 2001

Appl. No.:

09/967186

Inventors:

Jeffrey T. Ellis - San Francisco CA, US
Robert D. Ainsworth - Scotts Valley CA, US
Deborah L. Kilpatrick - Mountain View CA, US
Alex Q. Tilson - Burlingame CA, US
Bridget A. Hurley - San Francisco CA, US

Assignee:

Advanced Cardiovascular Systmes, Inc. - Santa Clara CA

International Classification:

A61B 5/05
A61B 5/00
A61M 25/00

US Classification:

600585, 600345

Abstract:

A guidewire with a sensor which can detect NO and/or superoxide levels is disclosed. This invention can be useful for in vivo analysis of vascular health.

US Patent:

7842012, Nov 30, 2010

Filed:

Feb 3, 2006

Appl. No.:

11/346771

Inventors:

Jeffrey T. Ellis - San Francisco CA, US
Robert D. Ainsworth - Scotts Valley CA, US
Deborah L. Kilpatrick - Mountain View CA, US
Alex Q. Tilson - Burlingame CA, US
Bridget A. Hurley - San Francisco CA, US

Assignee:

Advanced Cardiovascular Systems, Inc. - Santa Clara CA

International Classification:

A61M 5/178
A61M 25/00

US Classification:

60416413, 600585

Abstract:

A guidewire with a sensor which can detect NO and/or superoxide levels is disclosed. This invention can be useful for in vivo analysis of vascular health.

US Patent:

8017140, Sep 13, 2011

Filed:

May 21, 2007

Appl. No.:

11/804997

Inventors:

Syed Faiyaz Ahmed Hossainy - Fremont CA, US
Gordon Stewart - San Francisco CA, US
Deborah Kilpatrick - Los Altos CA, US
Jeffrey Ellis - San Francisco CA, US
Gene Park - Oakland CA, US
Gina Zhang - Fremont CA, US
Paul Consigny - San Jose CA, US
Yiwen Tang - San Jose CA, US

Assignee:

Advanced Cardiovascular System, Inc. - Santa Clara CA

International Classification:

A61F 13/00
A61F 2/00
A61K 9/14

US Classification:

424422, 424423, 424426, 424486

Abstract:

Drug-delivery stents capable of providing release of two or more drugs such as everolimus and estradiol are provided. The stents can be used for treating a disease such as restenosis and vulnerable plaque.

US Patent:

8052701, Nov 8, 2011

Filed:

Jun 2, 2003

Appl. No.:

10/453116

Inventors:

Daniel L. Cox - Palo Alto CA, US
Jeffrey Ellis - San Francisco CA, US
Timothy A. Limon - Cupertino CA, US

Assignee:

Abbott Cardiovascular Systems Inc. - Santa Clara CA

International Classification:

A61B 17/32

US Classification:

606159, 623 114, 606170

Abstract:

Methods and apparatuses for treating a vulnerable plaque are described herein. In one aspect of the invention, the exemplary apparatus includes a medical device to treat a vulnerable plaque within a body lumen, where the medical device is adapted to position a rupturing device to rupture a fibrous cap of a vulnerable plaque. In one particular embodiment, the medical device includes a rupturing wire having a predetermined pattern to enable the rupturing device to rupture the fibrous cap of the vulnerable plaque. Other methods and apparatuses are also described.

US Patent:

20050287184, Dec 29, 2005

Filed:

Jun 29, 2004

Appl. No.:

10/881540

Inventors:

Syed Hossainy - Fremont CA, US
Gordon Stewart - San Francisco CA, US
Deborah Kilpatrick - Los Altos CA, US
Jeffrey Ellis - San Francisco CA, US
Gene Park - Oakland CA, US
Gina Zhang - Fremont CA, US
Paul Consigny - San Jose CA, US
Yiwen Tang - San Jose CA, US

International Classification:

A61K031/56
A61K031/4745

US Classification:

424423000, 514171000, 514291000

Abstract:

Drug-delivery stents capable of providing release of two or more drugs such as everolimus and estradiol are provided. The stents can be used for treating a disease such as restenosis and vulnerable plaque.

US Patent:

20060135985, Jun 22, 2006

Filed:

Dec 21, 2004

Appl. No.:

11/022548

Inventors:

Daniel Cox - Palo Alto CA, US
Jeffrey Ellis - San Francisco CA, US
Jeong Lee - Diamond Bar CA, US
Klaus Kleine - Los Gatos CA, US
Alan Tannier - Temecula CA, US

International Classification:

A61M 29/00

US Classification:

606194000

Abstract:

A method including introducing an expandable body into a blood vessel at a point coextensive with a vulnerable plaque lesion, and expanding the expandable body from a first diameter to a different second diameter sufficient to modify the shape of an inner diameter of the blood vessel at the point coextensive with the lesion without rupturing the lesion. An apparatus including a cannula having a dimension suitable for insertion into a blood vessel and including an expandable body coupled thereto, the expandable body including a first outer diameter suitable for insertion through the blood vessel and a second outer diameter greater than the first diameter and having a maximum dimension to modify the shape of an inner diameter of the blood vessel and retain a same perimeter. A kit including a cannula including an expandable body and a stent. An expandable framework comprising a polymer material. An apparatus including an expandable body.

US Patent:

20140287033, Sep 25, 2014

Filed:

Jun 9, 2014

Appl. No.:

14/299771

Inventors:

- Santa Clara CA, US
Syed Faiyaz Ahmed Hossainy - Hayward CA, US
Irina Astafieva - Palo Alto CA, US
Florian N. Ludwig - Ebikon, CH
Paul M. Consigny - San Jose CA, US
Jeffrey T. Ellis - San Francisco CA, US
Florencia Lim - Union City CA, US

International Classification:

A61K 38/17

US Classification:

424451, 424400, 514 74

Abstract:

A method including introducing into a blood stream a delipidated high density lipoprotein (HDL) and a bioactive agent. A composition including a delipidated high density lipoprotein (HDL) and an auxiliary agent in a form suitable for delivery into a blood vessel. A composition including Apo A1 comprising a hydrophobic ligand suitable to interact with cell surface binding sites. A composition including Apo A1 and an agent selected to one of increase the ATP-binding cassette protein 1 (ABCA1) transporter expression in macrophages and protect ABCA1 from thiol-mediated degradation.